Value proposition

Vital. Verified. Valencell.TM

Accurate, intuitive digital health solutions that make chronic disease management easier.


Valencell is an acclaimed innovator of intuitive, accurate and easy to incorporate digital health solutions with a focus on addressing unmet needs in the prevention and management of chronic diseases.

Our proprietary biometric sensor technology, algorithms and machine learning analytics are protected by 150+ awarded patents, and power tens of millions of wearable and hearable devices on the market today.

Founded: Founded in 2006 and headquartered in Raleigh, North Carolina

Investors: Halma, Sonion, TDF Ventures, GII TECH, and WSJ Joshua Fund

Leadership
Kent Novak, Chairman, CEO
Steven LeBoeuf, Ph.D., Founder & President
Michael Aumer, Ph.D., VP of R&D
Jon Scrimshaw, Chief Financial Officer
Mark Felice, VP of Business Development and Licensing
Scott Downing, VP of Sales
Rebecca Cook, VP of Marketing

4601 Six Forks Road
Suite 103
Raleigh, NC 27609

info@valencell.com / www.valencell.com

physiological monitoring technology, real-time biometrics and physiological data, fitness technology, wearable technology, sensor technology, hearables, heart rate, active signal characterization, photoplethysmography, ppg, Blood pressure, machine learning, wearables, medtech, digital health monitoring, and blood pressure monitoring